NCT04574401View on ClinicalTrials.gov

A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

October 10, 2020

Primary Completion Date

September 20, 2021

Study Completion Date

September 20, 2021

Conditions

Prostate Cancer

Interventions

DRUG

IS-002

Intravenous injection of IS-002 Investigational Drug

Trial Locations (1)

94158

UCSF Medical Center, Mission Bay, San Francisco

Sponsors

Lead Sponsor

Intuitive Surgical

All Listed Sponsors

lead

Intuitive Surgical

INDUSTRY